Corcept Therapeutics Incorporated is a pharmaceutical company based in Albuquerque, NM, specializing in the development and commercialization of medications for Cushing Syndrome. Their flagship product, Korlym, is designed to modulate cortisol levels in patients with this condition. With a focus on research and clinical trials, Corcept aims to provide effective treatment options for individuals suffering from Cushing Syndrome.
Corcept Therapeutics Incorporated offers a range of informational resources on their website, including publications, research pipeline updates, and medical information requests. Committed to maintaining high standards, the company emphasizes that their website is not intended for investment advice or medical services, but rather serves as a platform for general information about their products and the conditions they address. By granting limited access to their site, Corcept aims to provide valuable insights to patients, healthcare professionals, and individuals interested in their therapeutic platform.
Generated from the website